Novohale Therapeutics, LLC announced that it expects to receive $30 million in funding from Tang Capital Management, LLC, Celon Pharma S.A.

Novohale Therapeutics, LLC announced that it will receive $30,000,000 in a round of funding on May 22, 2024. The transaction will include participation from new investors, Tang Capital Management, LLC for $10,000,000 and Celon Pharma S.A. for $20,000,000.